The opportunities of manufacturing in China are now an extremely important topic for pharmaceutical manufacturing companies to evaluate, especially as China is emerging as the largest and fastest growing economy in the world. With more than 1.3 billion people, China is one of the biggest potential sources of raw materials, including food grains, which has the potential to increase production by orders of magnitude in the coming years. There is also a burgeoning middle class of more than 10 million individuals who are buying new technology devices to benefit from the opportunities of manufacturing in China. This group of buyers is increasing its purchasing power every year, and there is no end in sight.
Biocitech, one of the leaders in the technology park, is looking at opportunities of manufacturing in China as a way to tap into this growing market. As China becomes an increasingly important trading partner for the United States and other developed countries, biotech is looking for resources to expand its business presence in China. There is also a burgeoning IT/computer technology sector with China leading the way in high-end technology. One of the challenges facing biotech is whether it can develop its own products to provide a competitive edge over its competitors.
Bioconductor RFID tags are a key element in developing the opportunities of manufacturing in China. The key element here is RFID technologies, which have become more efficient and reliable in the recent years. This allows for more accurate and timely data collection, which can be used to better monitor manufacturing processes at various sites throughout the factory. RFID technology is also helping to reduce costs and eliminate waste, both of which are encouraging factors for companies looking at the opportunities of manufacturing in China.
Another key element for biotech is its relationship with Semiconductor Corporation. Sanofi is a partner in several joint venture projects with Semiconductor Corporation. Semiconductor Corporation is one of the largest manufacturers of semiconductors and works closely with biotech. The opportunities of manufacturing in China include developing its own chips, but working also in partnership with Semiconductor Corporation to manufacture and market their products. Biocibur’s strategic alliance with sanofi also provides a means of getting its products to the Chinese market faster.
Biocibur looks at two major challenges facing companies in the opportunities of manufacturing in China. The first challenge is in improving its sourcing contract management and controlling its raw materials costs. The second challenge is in satisfying supply chain efficiency requirements to support its production in China. In these regards, biocibur has been looking at several solutions from leading manufacturers in Europe, India, Japan and the United States. Some of these solutions have been successful such as the use of packed foam as an in-plant material to support the weight bearing loads of its machines and the use of unloading doors to improve overall handling and access.
In recent years, Usana has been working on the development of machinery which will allow for the production of optical devices for medical purposes and other optical products for medical uses. Usana’s other products include robotic appliances that are used for food service equipment, which has been a success in the US. Usana’s partnership with Chinese-based Wanda Inc., which manufactures the popular Panda robots, has been very fruitful in the opportunities of manufacturing in China. This partnership allows for high volume productions of Panda products that will be distributed throughout the china and possibly the rest of the world. This is a big step forward for the opportunities of manufacturing in China.